Billionaire Profile

Global Rank

#2360

Image: Public domain | via Wikimedia Commons

Leopoldo Espinosa Abdalá

CEO, Rimsa

Real-Time Net Worth

$1.6B

As of December 2025

Age

Source

Pharmaceutical

Industry

healthcare

Citizenship

Biography

Leopoldo Espinosa Abdalá is a Mexican billionaire recognized for his significant contributions to the pharmaceutical industry. His net worth is estimated at $1.6 billion as of 2024. The source of his wealth stems from the pharmaceutical sector, particularly the 2016 sale of Rimsa, a pharmaceutical manufacturing company, to Teva Pharmaceuticals for $2.3 billion. Espinosa Abdalá's career began with his family's business, which he later led as executive president. His achievements include building Rimsa into a leading pharmaceutical provider in Mexico, developing patented medicines, and strategic business decisions. He has a very low public profile. After the sale of Rimsa, he and his brother largely withdrew from the public eye. The family is involved in philanthropic activities.

Wealth Over Time

In-Depth Profile

Early Life

Leopoldo Espinosa Abdalá comes from a family with a long history in business in Mexico. He became involved in the family's business early on, learning the nuances of managing large capital and the intricacies of the pharmaceutical market.

Rise to Success

Espinosa Abdalá, along with his brother Fernando, built a considerable fortune through the pharmaceutical company Rimsa. Founded by their father in 1970, Rimsa was a pharmaceutical distributor that later expanded into manufacturing. The company was known for its patented products, particularly fixed-dose drug combinations. Their success culminated in the 2016 sale of Rimsa to Teva Pharmaceuticals for $2.3 billion.

Key Business Strategies

Key to Espinosa Abdalá's success was the strategic development of Rimsa. Under his leadership, the company became a major player in the Mexican pharmaceutical market, with annual revenues exceeding $200 million. He focused on product development and obtaining patents for new medicines, which significantly boosted the company's value. A crucial factor in the company's growth was the identification and capitalization of market opportunities in the Mexican healthcare sector.

Philanthropy

Leopoldo Espinosa Abdalá is involved in philanthropic activities, supporting initiatives focused on education, healthcare, and community development.

Career Milestones

1970

Rimsa Foundation

Rimsa was founded by Espinosa Abdalá's father as a pharmaceutical distributor.

2016

Sale of Rimsa

Sold Rimsa to Teva Pharmaceuticals for $2.3 billion.

Philanthropy & Social Impact

Philanthropy

Education, Healthcare, and Community Development

Unknown

Supports initiatives in education, healthcare, and community development in Mexico.

Business Philosophy & Leadership

Notable Quotes

"Quote not available."

Leadership Principles

Strategic Vision

Demonstrates strategic vision in identifying and capitalizing on opportunities within the pharmaceutical industry.

Business Acumen

Exhibits strong business acumen in building and successfully selling Rimsa.

Controversies & Challenges

2016

Teva Lawsuit

Following the sale of Rimsa, Teva sued Leopoldo and Fernando Espinosa Abdalá claiming fraud and a breach of contract. The charges were mostly dismissed; as for breach of contract, the parties eventually settled for less than $200 million.

Unknown

Pandora Papers

The Espinosa Abdalá brothers were mentioned in the Pandora Papers, linked to offshore companies established in Geneva and other tax havens for investment diversification.